June 17, 2011
California’s biomedical industry has grown organically from ideas first germinated in the state’s universities. Through technology transfer, entrepreneurial commitment and investor financing, basic science discoveries have led to breakthrough technologies to better understand, diagnose, treat and cure a broad range of medical disorders. Read More
June 17, 2011
The bill creates a process for approval of “biosimilars” or “follow-on biologics” while protecting patient health and safety, lowering health care costs, and providing adequate incentives for innovation. Representatives Eshoo and Inslee were the lead sponsors of two separate biosimilar bills during the 110th Congress, and now have one bill with Rep. Barton, ranking member […]
June 17, 2011
The bill creates a process for approval of “biosimilars” or “follow-on biologics” while protecting patient health and safety, lowering health care costs, and providing adequate incentives for innovation. Representatives Eshoo and Inslee were the lead sponsors of two separate biosimilar bills during the 110th Congress, and now have one bill with Rep. Barton, ranking member […]
June 17, 2011
One somewhat overlooked element of the Obama administration’s proposed federal budget is its desire to create the first regulatory process for government approval of so-called “follow-on biologics,” or generic versions of drugs manufactured by living organisms. These medicines are often used in treatments such as cancer, anemia, psoriasis and rare diseases, where little room for […]
June 17, 2011
At a time when cancer and heart disease are the nation’s and the world’s top killers, biopharmaceutical research companies headquartered in California are developing 243 of the 1,186 medicines in development for those dreaded diseases. Read More
June 17, 2011
At a time when cancer and heart disease are the nation’s and the world’s top killers, biopharmaceutical research companies headquartered in California are developing 243 of the 1,186 medicines in development for those dreaded diseases. Read More
June 16, 2011
October 27, 2011 Embassy Suites Dublin Dublin, OH Read More
June 16, 2011
BioOhio BioEnterprise Corporation, Cleveland BioStart Edison Biotechnology Institute – Ohio University TechColumbus Office of Governor John Kasich Ohio Department of Health Ohio House of Representatives Ohio State Legislature Ohio State Medical Association Ohio State Senate
June 16, 2011
BioOhio represents and advocates for Ohio’s bioscience community to improve business environment and public funding climate. Alone or in conjunction with partners and members, BioOhio pursues both a proactive and responsive advocacy program. Read More
June 16, 2011
BioOhio represents and advocates for Ohio’s bioscience community to improve business environment and public funding climate. Alone or in conjunction with partners and members, BioOhio pursues both a proactive and responsive advocacy program. Read More
